LBSAX
Price
$33.72
Change
-$0.38 (-1.11%)
Updated
Sep 6 closing price
VVIAX
Price
$65.30
Change
-$0.84 (-1.27%)
Updated
Sep 6 closing price
Ad is loading...

LBSAX vs VVIAX

Header iconLBSAX vs VVIAX Comparison
Open Charts LBSAX vs VVIAXBanner chart's image
Columbia Dividend Income A
Price$33.72
Change-$0.38 (-1.11%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$65.30
Change-$0.84 (-1.27%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
LBSAX vs VVIAX Comparison Chart
Loading...
VS
LBSAX vs. VVIAX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LBSAX is a Buy and VVIAX is a Buy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 183B vs. LBSAX (41.1B). VVIAX pays higher dividends than LBSAX: VVIAX (2.36) vs LBSAX (1.51). LBSAX was incepted earlier than VVIAX: LBSAX (22 years) vs VVIAX (24 years). LBSAX is a more actively managed with annual turnover of: 17.00 vs. VVIAX (10.00). LBSAX has a lower initial minimum investment than VVIAX: LBSAX (2000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 19.30 vs. LBSAX (16.09). LBSAX (55.81) and VVIAX (53.51) have equivalent 5 years return.
LBSAXVVIAXLBSAX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years24 years-
Gain YTD13.13913.50697%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets41.1B183B22%
Annual Yield % from dividends1.512.3664%
Returns for 1 year16.0919.3083%
Returns for 3 years16.9219.6886%
Returns for 5 years55.8153.51104%
Returns for 10 years88.34107.5782%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDYN14.080.47
+3.45%
Grid Dynamics Holdings
USEG0.910.01
+1.00%
US Energy Corp
BCE35.950.07
+0.20%
BCE
LNKB6.15N/A
N/A
LINKBANCORP
CRNX50.98-1.82
-3.45%
Crinetics Pharmaceuticals